Gastrointestinal Cancer

Protocol Title Protocol Number Control Number Principal Investigator
Phase III Intergroup Trial of Adjuvant Chemoradiation After Resection of Gastric or Gastroesophageal Adenocarcinoma CALGB-80101 FH03-071 Dr. Allen Terzian

A Phase III Randomized Double-Blind Study of Adjuvant STI1571 (Gleevec) versus Placebo in Patients Following the Resection of Primary Gastrointestinal Stromal Tumor (GIST) ACOSOG Z9001 FH04-091 Dr. Allen Terzian

A Randomized Phase III Trial of Gemcitabine Plus Bevacizumab (NSC #704865 IND #7921) versus Gemcitabine Plus Placebo in Patients with Advanced Pancreatic Cancer CALGB 80303 FH05-101 Dr. Allen Terzian

A Phase III Clinical Trial Comparing Infusion 5-Flourourcil (5-FU), Leucovorin, and Oxaliplatin (mFOLFOX6) Every Two Weeks with Bevacizumab to the Same Regimen Without Bevacizumab for the Treatment of Patients with Resected Stages II and III Carcinoma of the Colon NSABP C-08 FH05-113 Dr. Allen Terzian

Randomized Phase II Trial of Neoadjuvant Combined Modality Therapy for Locally Advanced Rectal Cancer RTOG 0247 FH05-115 Dr. Shari Rudoler

A Randomized Phase III Study Comparing 5-FU, Leucovorin and Oxaliplatin versus 5-FU, Leucovorin, Oxaliplatin and Bevacizumab in Patients with Stage II Colon Cancer at High Risk for Recurrence to Determine Prospectively the Prognostic Value of Molecular Markers (Revised Protocol Addendum #5 dated January 11, 2006; Revised Consent dated 3/06) E5202 FH05-122 Dr. Allen Terzian